Huntington's disease: regional alteration in muscarinic cholinergic receptor binding in human brain. |
| |
Authors: | G J Wastek L Z Stern P C Johnson H I Yamamura |
| |
Institution: | 1. Departments of Pharmacology, Neurology, The University of Arizona, College of Medicine, Tucson, AZ 85724, USA;7. Pathology The University of Arizona, College of Medicine, Tucson, AZ 85724, USA |
| |
Abstract: | Huntington's Disease, an autosomal dominant neurological disorder, is characterized by diffuse neuronal degeneration particularly in the basal ganglia and cerebral cortex. The purpose of this study was to examine various discrete regions of choreic and control brains for alterations in muscarinic cholinergic receptor binding and choline acetyltransferase (ChAc) activity. Nine postmortem brains, three from patients with Huntington's Disease and six controls, were dissected into 17 discrete regions. Each regional homogenate was assayed for muscarinic receptor concentration by measuring specific membrane binding of 3H]-QNB, a potent muscarinic antagonist which selectively labels brain muscarinic receptors. Aliquots from each brain region were also assayed for ChAc activity. Of significance was the marked reduction in specific 3H]-QNB receptor binding in the caudate nucleus, putamen and globus pallidus of choreic brain while no significant alterations were detected in other brain regions. Significant decreases in ChAc activity were found in the caudate nucleus, putamen, and globus pallidus with no alterations in ChAc activity in the rest of the brain regions examined. The tissues were chosen such that protein levels were similar in both choreic and normal brain samples. The apparent reduction in the number of muscarinic cholinergic receptors in the choreic brains suggests that treatment with cholinomimetic drugs might be beneficial in Huntington's Disease. |
| |
Keywords: | To whom reprint requests should be sent |
本文献已被 ScienceDirect 等数据库收录! |
|